Evaluation and Management E/M NRNP 6675

College of Nursing-PMHNP, Walden University

NRNP 6675: PMHNP Care Across the Lifespan II

Faculty Name

Assignment Due Date

Instructions

Identifying Information

Time spent for evaluation: 0900am-0957am

Chief Complaint

HPI

Today, the client denied symptoms of depression, anergia, anhedonia, amotivation, no anxiety, denied frequent worry, reports feeling restlessness, no reported panic symptoms, and no reported obsessive/compulsive behaviors. The client denies active SI/HI ideations, plans or intent. There is no evidence of psychosis or delusional thinking.

Client denied past episodes of hypomania, hyperactivity, erratic/excessive spending, involvement in dangerous activities, self-inflated ego, grandiosity, or promiscuity. Client reports increased irritability and easily frustrated, loses things easily, makes mistakes, and has a hard time focusing and concentrating, affecting her job.

Has low frustration tolerance, sleeping 5–6 hrs/24hrs reports nightmares of a previous rape, isolates, fearful of going outside, has missed several days of work, appetite decreased. She has somatic concerns with GI upset and headaches. Client denied any current binging/purging behaviors, denied withholding food from self, or engaging in anorexic behaviors. No self-mutilation behaviors.

Diagnostic Screening Results

PHQ 9= 0 with symptoms rated as no difficulty in functioning
Interpretation of Total Score
Total Score Depression Severity 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression

GAD 7= 2 with symptoms rated as no difficulty in functioning
Interpreting the Total Score:
Total Score Interpretation ≥10 Possible diagnosis of GAD; confirm by further evaluation 5 Mild Anxiety 10 Moderate anxiety 15 Severe anxiety

MDQ screen negative

PCL-5 Screen 32

Past Psychiatric and Substance Use Treatment

·       Previous Psychiatric Hospitalizations:  denied

·       Previous Detox/Residential treatments: one for abuse of stimulants and cocaine in 2015

·       Previous psychotropic medication trials: sertraline (became suicidal), trazodone (worsened nightmares), bupropion (became suicidal), Adderall (began abusing)

·       Previous mental health diagnosis per client/medical record: GAD, Unspecified Trauma, PTSD, Stimulant use disorder, ADHD confirmed by school records

Substance Use History

Have you used/abused any of the following (include frequency/amt/last use):

Any history of substance-related:

·       Blackouts:  +

·       Tremors:   –

·       DUI: –

·       D/T’s: –

·       Seizures: –

Longest sobriety reported since 2015—stayed sober maintaining sponsor, sober friends, and meetings

.

Psychosocial History

Employed at local tanning bed salon

Education: High School Diploma

Denied current legal issues.

Suicide / Homicide Risk Assessment

·       Suicidal Ideas or plans – no

·       Suicide gestures in past – no

·       Psychiatric diagnosis – yes

·       Physical Illness (chronic, medical) – no

·       Childhood trauma – yes

·       Cognition not intact – no

·       Support system – yes

·       Unemployment – no

·       Stressful life events – yes

·       Physical abuse – yes

·       Sexual abuse – yes

·       Family history of suicide – unknown

·       Family history of mental illness – unknown

·       Hopelessness – no

·       Gender – female

·       Marital status – single

·       White race

·       Access to means

·       Substance abuse – in remission

PROTECTIVE FACTORS FOR SUICIDE:

·       Absence of psychosis – yes

·       Access to adequate health care – yes

·       Advice & help seeking – yes

·       Resourcefulness/Survival skills – yes

·       Children – no

·       Sense of responsibility – yes

·       Pregnancy – no; last menses one week ago, has Norplant

·       Spirituality – yes

·       Life satisfaction – “fair amount.”

·       Positive coping skills – yes

·       Positive social support – yes

·       Positive therapeutic relationship – yes

·       Future oriented – yes

Suicide Inquiry: Denies active suicidal ideations, intentions, or plans. Denies recent self-harm behavior. Talks futuristically. Denied history of suicidal/homicidal ideation/gestures; denied a history of self-mutilation behaviors

Global Suicide Risk Assessment: The client is found to be at low risk of suicide or violence. However, the risk of lethality increased under the context of drugs/alcohol.

No required SAFETY PLAN related to low risk

Mental Status Examination

There is no evidence of looseness of association or flight of ideas. Her mood is anxious, mildly irritable, and her affect is appropriate to her mood. She was smiling at times in an appropriate manner. She denies any auditory or visual hallucinations. There is no evidence of any delusional thinking.

She denies any current suicidal or homicidal ideation. Cognitively, She is alert and oriented to all spheres. Her recent and remote memory is intact. Her concentration is fair. Her insight is good.

Clinical Impression

Moods are anxious and irritable. She has ongoing reported symptoms of re-experiencing, avoidance, and hyperarousal of her past trauma experiences; persistent subsyndromal symptoms related to her past ADHD diagnosis and exacerbated by her PTSD diagnosis.

She denied vegetative symptoms of depression, no evident mania/hypomania, no psychosis, denied anxiety symptoms. Denied current cravings for drugs/alcohol, exhibits no withdrawal symptoms, has somatic concerns of GI upset and headaches.

At the time of disposition, the client adamantly denies SI/HI ideations, plans, or intent and has the ability to determine right from wrong and can anticipate the potential consequences of behaviors and actions. She is at low risk for self-harm based on her current clinical presentation and her risk and protective factors.

Diagnostic Impression

[Student to provide DSM-5 and ICD-10 coding]

Double click inside this text box to add/edit text. Delete placeholder text when you add your answers.

Treatment Plan

·       Increase fluoxetine 40mg PO daily for PTSD #30 1 RF

·       Continue with atomoxetine 80mg PO daily for ADHD.  #30 1 RF

Instructed to call and report any adverse reactions.

Future Plan: monitor for decreased re-experiencing, hyperarousal, and avoidance symptoms; monitor for improved concentration, less mistakes, less forgetful

2)       Education: Risks and benefits of medications are discussed, including non-treatment. Potential side effects of medications discussed. Verbal informed consent was obtained.

Not to drive or operate dangerous machinery if feeling sedated.

Not to stop the medication abruptly without discussing it with providers.

Discussed risks of mixing medications with OTC drugs, herbal, alcohol/illegal drugs. Instructed to avoid this practice. Praised and Encouraged ongoing abstinence. Maintain support system, sponsors, and meetings.

Discussed how drugs/ETOH affects mental health, physical health, sleep architecture.

3)       Patient was educated about therapy and services of the MHC, including emergent care. Referral was sent via email to the therapy team for PET treatment.

4)       Patient has emergency numbers: Emergency Services 911, the national Crisis Line 800-273-TALK, the MHC Crisis Clinic. Patient was instructed to go to the nearest ER or call 911 if they become actively suicidal and/or homicidal.

5)       Time allowed for questions and answers provided. Provided supportive listening. Patient appeared to understand the discussion and appears to have the capacity for decision making via verbal conversation.

6)       RTC in 30 days

7)       Follow up with PCP for GI upset and headaches, reviewed PCP history and physical dated one week ago, and include lab results

Patient is amenable with this plan and agrees to follow treatment regimen as discussed.